IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 81 filers reported holding IGM BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142 | -96.1% | 17 | -95.7% | 0.00% | – |
| Q2 2023 | $3,674 | -4.8% | 398 | +41.6% | 0.00% | – |
| Q1 2023 | $3,861 | -47.5% | 281 | -35.0% | 0.00% | – |
| Q4 2022 | $7,348 | -78.4% | 432 | -70.5% | 0.00% | – |
| Q3 2022 | $34,000 | +21.4% | 1,466 | -4.4% | 0.00% | – |
| Q2 2022 | $28,000 | -56.9% | 1,534 | -37.1% | 0.00% | – |
| Q1 2022 | $65,000 | +550.0% | 2,437 | +608.4% | 0.00% | – |
| Q4 2021 | $10,000 | -95.6% | 344 | -90.1% | 0.00% | – |
| Q3 2021 | $229,000 | -52.9% | 3,474 | -40.6% | 0.00% | -100.0% |
| Q2 2021 | $486,000 | +7.0% | 5,849 | -1.2% | 0.00% | 0.0% |
| Q1 2021 | $454,000 | +64.5% | 5,921 | +89.2% | 0.00% | 0.0% |
| Q4 2020 | $276,000 | -38.5% | 3,130 | -48.6% | 0.00% | 0.0% |
| Q3 2020 | $449,000 | +1852.2% | 6,092 | +1846.3% | 0.00% | – |
| Q2 2020 | $23,000 | – | 313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |